Cti biopharma 10k
WebApr 7, 2024 · CTI BioPharma Corp does not have a meaningful P/E due to negative earnings over the last 12 trailing months. CTI BioPharma Corp’s trailing 12-month revenue is $53.9 million with a -172.4% profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-0.216 per share for the … WebIn May 2014, we changed our name from “Cell Therapeutics, Inc.” to “CTI BioPharma Corp.” We completed our initial public offering in 1997 and our shares are listed on The …
Cti biopharma 10k
Did you know?
WebApr 1, 2024 · CTI is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a … WebMar 20, 2024 · CTI develops novel therapies for patients with rare blood-related cancers by uncovering the underlying scientific drivers of their disease. Learn More Approved in the U.S. for adults with myelofibrosis …
WebOct 14, 2024 · CTI BioPharma. @ctibiopharma. Developing novel therapies for patients with rare blood-related cancers by uncovering the underlying scientific drivers of their disease. Seattle, WA ctibiopharma.com Joined …
WebMar 25, 2024 · At CTI BioPharma we measure success in terms of our impact on patient lives. We are committed to acting on behalf of patients courageously facing cancer, moving forward with persistence in our pursuit of creating life-saving medicines. If you are interested in joining our efforts, please visit our Career page to view current opportunities. WebAnnual Report. If you would like to receive a printed copy of the current annual report, please call. 800.215.2355 or 206.272.4345, or complete our Information Request form. …
WebMar 1, 2024 · We opine that CTI BioPharma's current set-up represents an attractive risk-reward scenario with ~50% potential downside (around cash value of $1/share) and ~320% potential upside (bull case $7.6 ...
WebJul 18, 2024 · Shares of CTI BioPharma Corp. ( CTIC -0.38%) plunged 41.3% as of 11:24 a.m. EDT on Wednesday after the company provided an update from its meeting with the U.S. Food and Drug Administration (FDA ... raypak 206a pool heater manualWeb- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood … simply be gold shoesWebMar 31, 2024 · SEATTLE, March 31, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the fourth quarter and full year ended … raypak 206a natural gas pool heaterWebMar 20, 2024 · The employees received options to purchase an aggregate of 124,000 shares of CTI BioPharma common stock. The options will be issued upon each employee's grant date (the "Grant Date"), and all stock options included within the equity inducement awards will have an exercise price equal to the closing price of CTI BioPharma common … simply be green dressWebCTI BioPharma Corp. a biopharmaceutical company, develops, acquires, and commercializes oncology products for cancer treatment. Its development portfolio … raypak 206a pool heater partsWebMar 6, 2024 · You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and the related … raypak 206a pool heater reviewsWebAug 24, 2024 · CTI BioPharma Corp. Aug 24, 2024, 07:00 ET. SEATTLE, Aug. 24, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced the appointment of Diane Parks to its Board of Directors. Ms. raypak 206btu propane pool heater